Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07155213 · ClinicalTrials.gov registry record · Early Phase 1

Adapted High-Intensity Virtual Reality Exergaming

A Early Phase 1 study of Cerebral Palsy, sponsored by University of Alabama at Birmingham.

Active
Registry status
Early Phase 1
Development phase
4
Enrollment target
1
Study location

NCT07155213 is a Early Phase 1 study of Cerebral Palsy that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 4 participants, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07155213, a Early Phase 1 study of Cerebral Palsy, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.

ACTIVE NOT RECRUITING
Registry status
Early Phase 1
Development phase
4 participants
Enrollment target
1
Study location

Study Summary

This study will test the acceptability and benefits of a home-based high-intensity virtual reality exercise program for young people with physical disabilities. The program will last 6 weeks. There will be a total of two visits to the laboratory for exercise-related health assessments. The program includes head-mounted displays (Meta Quest) and off-the-shelf games.

Conditions Studied

Interventions

  • BEHAVIORAL Virtual reality exergaming

Study Locations (1)

Alabama

  • UAB Wellness Health and Research Facility - Birmingham

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2025-09-03
Est. Completion 2026-04-01
Phase Early Phase 1

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT07155213

The ClinicalTrials.gov registry entry for NCT07155213 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (98% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cerebral Palsy appearing as the primary indexed condition, and to 1 intervention - of which Virtual reality exergaming is the first listed.

NCT07155213 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT07155213 about?

NCT07155213 is a clinical study titled "Adapted High-Intensity Virtual Reality Exergaming". This study will test the acceptability and benefits of a home-based high-intensity virtual reality exercise program for young people with physical disabilities. The program will last 6 weeks. There will be a total of two visits to the laboratory for exercise-related health assessments. The program i...

What is the current status of trial NCT07155213?

This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 4 participants. The study started on 2025-09-03. Estimated completion is 2026-04-01.

What conditions does trial NCT07155213 study?

This clinical trial studies the following conditions: Cerebral Palsy.

What interventions are being tested in trial NCT07155213?

The interventions under investigation include: Virtual reality exergaming (BEHAVIORAL).

Who is sponsoring clinical trial NCT07155213?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07155213 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cerebral Palsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.